After his late wife’s battle with breast cancer, Hon Hai Precision Industry chairman and Taiwan’s richest man Terry Gou started the Yonglin Healthcare Foundation, with the aim of using the best of technology wherever it was developed to take the fight to this disease.Read more
IEK Deputy General Director Jim Chung (left) and JRI Managing Director Hiroshi Matsunaga (right).
The increasing elderly population in both Taiwan and Japan has driven growing demand for medical devices.Read more
To take advantage of its strong science base and a growing number of small innovative companies, Taiwan’s burgeoning biopharmaceutical industry will need to start planning now to develop personnel skilled enough in GMP manufacturing and clinical trials to meet the demands and rigors of such a highly technical field.Read more
Baxter International Inc. (NYSE: BAX) and ScinoPharm Taiwan, Ltd. (TWSE: 1789) last week announced a strategic partnership to develop, manufacture and commercialize five injectable generic drugs used in a range of cancer treatments, including lung cancer, multiple myeloma and breast cancer, as well as medication to treat nausea and vomiting, common side effects of chemotherapy.Read more
Los Angeles-headquartered Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a manufacturer of a key protein utilized in immunotherapy development pipelines, and Taiwanese biopharmaceutical manufacturer Amaran Biotechnology, Inc., announced that they had entered into an exclusive multi-year supply agreement in connection with clinical development studies of immunotherapies for metastatic breast cancer and other cancers.Read more
Since its establishment in 2009, Zhenjuntang Biotechnology Co. Ltd. has invested more than NT$2.2 billion across the Taiwan Strait to manage 158 operation centers in 21 of China’s provinces.Read more